Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in a deal worth EUR 1.5 billion. This move comes after more than 25 years of successful collaboration, driven by a strategic repositioning at dsm-firmenich. Novonesis CEO Ester Baiget expressed excitement over the acquisition,…
Novartis signs agreement to acquire Anthos Therapeutics for $925 million upfront
LONDON: Novartis has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, clinical-stage biopharmaceutical company. Under the agreement, Novartis will pay USD 925 million upfront, with potential additional payments of up to USD 2.15 billion upon achieving regulatory and sales milestones. The transaction is expected to close in the first half of 2025,…
Orion Minerals names Kevin Moxham as new COO
SYDNEY: Orion Minerals Limited (ASX/JSE: ORN) announced the appointment of Kevin Moxham as its new Chief Operating Officer, effective from February 10, 2025. Moxham’s appointment marks a critical juncture for the company, as it gears up to transition from exploration to mine development in South Africa’s Northern Cape region. Moxham brings 40 years of experience…
Haydale announces filing for insolvency of U.S. subsidiary
LONDON: Haydale (AIM: HAYD), an advanced materials group, announced that it has filed for insolvency for its wholly owned subsidiary, Haydale Ceramic Technologies LLC (HCT), in the state of Georgia. This action is part of the Group’s restructuring efforts following a business review concluded on December 23, 2024. The Group plans to sell HCT’s assets…
Fifteenth raises $8.25 million in seed funding to revolutionize tax preparation for tech professionals
SAN FRANCISCO: Fifteenth, a tax solution designed to meet the unique needs of founders, investors, executives, and tech professionals with complex financial situations, announced Tuesday it has raised $8.25 million in seed funding. The funding round was led by A and General Catalyst, with participation from SV Angel and several prominent angel investors, including Swapnil Jain,…
Cotiviti to acquire Edifecs, enhancing healthcare data interoperability
SALT LAKE CITY: Cotiviti, a leader in data-driven healthcare solutions, announced today that it has entered into an agreement to acquire Edifecs, a pioneer in healthcare data interoperability. The combined platform aims to enhance connectivity between payers and providers, increase collaboration in the delivery of care, and accelerate the deployment of value-added solutions within the…
Summit Minerals appoints Dr. Matthew Cobb as CEO
MOUNT HAWTHORN: Summit Minerals Limited (ASX:SUM) announced significant leadership changes on Monday, aimed at advancing its Equador Niobium and Rare Earth Elements (REE) Project in northeast Brazil. The company has appointed Dr. Matthew Cobb as its new Chief Executive Officer, effective March 10, 2025. Dr. Cobb, a seasoned geologist with over 20 years of experience…
Patronus Resources launches takeover bid for Matsa Resources
PERTH: Patronus Resources Limited (ASX: PTN) announced on Monday an on-market takeover offer for all outstanding shares of Matsa Resources Limited (ASX: MAT), a move that could significantly reshape the gold exploration and development landscape in Western Australia. The offer, priced at A$0.045 per share, values Matsa at approximately A$33 million based on its current…
MedicAlert and Careteq partner to enhance medication safety for Australians
MELBOURNE: Careteq Limited (ASX: CTQ), a clinical healthtech company specializing in innovative medication management, has announced a strategic partnership with MedicAlert Foundation Australia to improve health outcomes for Australians with complex medical conditions. The collaboration aims to address medication-related harm by combining MedicAlert’s medical identification services with Careteq’s medication management expertise. Medication-related harm is a…
Cardiogeni signs MoU with Sheikh Al Qassimi for £20 million investment
LONDON: Cardiogeni (AQSE: CGNI), a UK-based clinical-stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans, has announced the signing of a memorandum of understanding (MoU) with the Private Office of Sheikh Al Qassimi. This agreement is set to facilitate direct investment and funding for the company’s clinical trials focused on novel heart failure…
Moho Resources sells Empress Springs Project for $1.258 million
PERTH: Moho Resources Limited (ASX: MOH) has announced the sale of its Empress Springs Project in Western Queensland to Qld Aus Graphite Pty Ltd (QAG) for a total consideration of approximately $1.258 million. The transaction includes an initial cash payment of $258,000 upon completion, with an additional $1 million deferred payment due 12 months later….
Nanoveu signs deal to acquire Embedded A.I. Systems
PERTH: Nanoveu Limited (ASX: NVU) announced on February 10, 2025, that it has executed a binding Share Sale Agreement to acquire 100% of Embedded A.I. Systems Pte. Ltd. (EMASS), a leading System-on-Chip (SoC) semiconductor design company. This strategic acquisition positions Nanoveu to accelerate its growth in AI-driven edge semiconductor solutions, targeting markets such as wearables,…